← Back
M

$ Value

$0

Shares

18,656

Price

$0

Filed

Oct 17

Insider

Name

Siegrist Jonathan Philip

Title

EVP of R&D & CTO

CIK

0002040321

Roles

Officer

Transaction Details

Transaction Date

2025-10-15

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

37,314

Footnotes

Reflects release of restricted stock units that were previously reported on a Form 3. | Disposition of shares, as set forth above, was in connection with the Issuer's withholding of common shares to satisfy tax withholding obligations related to the issuance of common shares upon release of restricted stock units. | Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. | 18,656 shares vested on October 15, 2025; the remaining 37,314 shares will vest in equal installments on October 15, 2026 and October 15, 2027.

Filing Info

Accession No.

0002040321-25-000005

Form Type

4

Issuer CIK

0001906324

Siegrist Jonathan Philip's History

Date Ticker Type Value
2026-01-30 QDEL A $0
2026-01-30 QDEL A $0
2026-01-29 QDEL A $0
2026-01-29 QDEL F $28K
2026-01-29 QDEL M $0
2025-10-15 QDEL A $0
2025-10-15 QDEL F $182K
2025-10-15 QDEL M $0

Other Insiders at QDEL (90d)

Insider Bought Sold Last
Blaser Brian J.
President and CEO
$249K 2026-02-13
Strobeck Matthew $240K 2026-02-13
Busky Joseph M.
Chief Financial Officer
$80K 2026-03-28
SISITSKY NATHANIEL
Chief Legal Officer
2026-04-15
Hodges Michelle A
Chief Legal Officer
2026-02-08
Bowman Ronald Lee
Chief Human Resources Officer
2026-01-30
Siegrist Jonathan Philip
EVP of R&D & CTO
2026-01-30
McLellan Philip D.
Chief Operations Officer
2026-01-31